EP
ACOR
Elkfork Partners’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-8,932
| Closed | -$68K | – | 1073 |
|
|
2019
Q2 | $68K | Buy |
8,932
+2,068
| +30% | +$15.7K | ﹤0.01% | 985 |
|
|
2019
Q1 | $91K | Hold |
6,864
| – | – | ﹤0.01% | 929 |
|
|
2018
Q4 | $107K | Hold |
6,864
| – | – | ﹤0.01% | 886 |
|
|
2018
Q3 | $135K | Hold |
6,864
| – | – | ﹤0.01% | 914 |
|
|
2018
Q2 | $197K | Hold |
6,864
| – | – | 0.01% | 803 |
|
|
2018
Q1 | $162K | Hold |
6,864
| – | – | ﹤0.01% | 844 |
|
|
2017
Q4 | $147K | Buy |
6,864
+2,464
| +56% | +$52.8K | ﹤0.01% | 861 |
|
|
2017
Q3 | $104K | Buy |
4,400
+770
| +21% | +$18.2K | ﹤0.01% | 890 |
|
|
2017
Q2 | $71K | Buy |
3,630
+1,716
| +90% | +$33.6K | ﹤0.01% | 934 |
|
|
2017
Q1 | $40K | Buy |
1,914
+110
| +6% | +$2.3K | ﹤0.01% | 944 |
|
|
2016
Q4 | $34K | Buy |
+1,804
| New | +$34K | ﹤0.01% | 933 |
|